NUDT15 and Decreased total leukocyte count: From previous studies, patients carrying one or more of the loss-of-function missense variants were found to have increased risk of developing leukopenia during thiopurine therapy [26]; thus, the eight patients (13.3%) with one or more mutant alleles were identified to have thiopurine intolerance by NUDT15 genotyping.